FABIOR (Mayne Pharma LLC)
Welcome to the PulseAid listing for the FABIOR drug offered from Mayne Pharma LLC. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mayne Pharma LLC |
| NON-PROPRIETARY NAME: | tazarotene |
| SUBSTANCE NAME: | TAZAROTENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | AEROSOL, FOAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-03-10 |
| END MARKETING DATE: | 0000-00-00 |
FABIOR HUMAN PRESCRIPTION DRUG Details:
| Item Description | FABIOR from Mayne Pharma LLC |
| LABELER NAME: | Mayne Pharma LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/g) |
| START MARKETING DATE: | 2017-03-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51862-295_36320220-2d8d-4854-84a4-924ae33ffb81 |
| PRODUCT NDC: | 51862-295 |
| APPLICATION NUMBER: | NDA202428 |
Other TAZAROTENE Pharmaceutical Manufacturers / Labelers:
